Immune Response in the SAPHO Syndrome

See also
Status	Clinical Trial	Phase
Completed	`NCT02544659` - Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome	Phase 1
Recruiting	`NCT04596462` - Characterizing SAPHO With 68Ga-FAPI PET/CT	Early Phase 1
Recruiting	`NCT06011889` - Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome	Phase 2/Phase 3

See also

Status

Clinical Trial

Phase

Completed

NCT02544659 - Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome

Phase 1

Recruiting

NCT04596462 - Characterizing SAPHO With 68Ga-FAPI PET/CT

Early Phase 1

Recruiting

NCT06011889 - Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

Phase 2/Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01688219
Study type	Observational
Source	Assistance Publique - Hôpitaux de Paris
Contact
Status	Completed
Phase	N/A
Start date	November 2005
Completion date	May 2008

Immune Response in the SAPHO Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms